SCHEMBL13385409

SCHEMBL13385409

N#Cc1cc(Cl)c(-c2c(F)cccc2Cl)c(Cl)n1

nearest known ligand 0.39

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
PSMB8 P28062 2/20 0.39
ALDH1A1 P00352 3/20 0.38
HTT P42858 2/20 0.38
PTGES O14684 7/20 0.36
GAA P10253 3/20 0.36
JAK2 O60674 1/20 0.36
TYK2 P29597 1/20 0.35
SMN1; SMN2 Q16637 2/20 0.35
LMNA P02545 1/20 0.35
MAPK1 P28482 1/20 0.35
KHK P50053 1/20 0.34
CHEK1 O14757 1/20 0.34
MAPT P10636 2/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
GFER P55789 1/20 0.33
PDE2A O00408 1/20 0.33
PDE10A Q9Y233 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3277093 0.79 PTGES (0.40) HTTPTGESJAK2SMN1; SMN2LMNA
SCHEMBL14384427 0.76 PTGES (0.38) ALDH1A1HTTPTGESJAK2SMN1; SMN2
SCHEMBL16008014 0.74 KHK (0.38) PSMB8ALDH1A1GAASMN1; SMN2LMNA
SCHEMBL13385411 0.73 SMN1; SMN2 (0.37) HTTPTGESGAAJAK2SMN1; SMN2
SCHEMBL3277805 0.72 GAA (0.38) PSMB8ALDH1A1HTTPTGESGAA
SCHEMBL19610576 0.72 MET (0.38) PSMB8ALDH1A1PTGESGAAJAK2
SCHEMBL3276748 0.72 SMN1; SMN2 (0.40) HTTPTGESJAK2SMN1; SMN2LMNA
SCHEMBL3803033 0.72 PTGES (0.44) ALDH1A1HTTPTGESGAAJAK2
SCHEMBL13385410 0.71 JAK2 (0.39) HTTPTGESGAAJAK2TYK2
SCHEMBL3280715 0.70 CCR1 (0.51) HTTPTGESJAK2SMN1; SMN2LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7695728-B2 2-substituted pyridines, processes for their preparation and their use for controlling harmful fungi BASF AKTIENGESELLSCHAFT (DE) 2010-04-13 US disclosed
US-7695728-B2 2-substituted pyridines, processes for their preparation and their use for controlling harmful fungi BASF AKTIENGESELLSCHAFT (DE) 2010-04-13 US disclosed
US-20070259919-A1 2-Substituted Pyridines, Processes for their Preparation and Their Use for Controlling Harmful Fungi BASF AKIENGESELLSCHAFT (DE) 2007-11-08 US disclosed
US-20070259919-A1 2-Substituted Pyridines, Processes for their Preparation and Their Use for Controlling Harmful Fungi BASF AKIENGESELLSCHAFT (DE) 2007-11-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070259919-A1 2-Substituted Pyridines, Processes for their Preparation and Their Use for Controlling Harmful Fungi CYP4X1, CYCS, CYP2S1 PSMB8 2407/4885ALDH1A1 2365/4885HTT 3132/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.